No Data
No Data
China Merchants: Maintains JD-SW "Buy" rating and raises Target Price to 209 Hong Kong dollars.
China Merchants released a Research Report stating that it maintains a "Buy" rating for JD-SW (09618) and raises the Target Price for H shares from 179 HKD to 209 HKD. JD Group's revenue in the fourth quarter accelerated year-on-year growth to 13%, reaching 3.47 billion RMB, exceeding the bank's expectations, with JD Retail revenue increasing by 15% year-on-year. The gross margin rose by 22% year-on-year, benefitting from an increase in profit margin of 1.1 percentage points to 15.3%. The non-GAAP net profit rose by 34% year-on-year, higher than the bank's expectations. The bank anticipates that this year, the group's revenue will increase by 9.2% year-on-year, including JD Retail and JD.
China Merchants: iFlytek Medical Technology is expected to maintain long-term competitiveness in medical AI.
China Merchants released a Research Report stating that iFlytek Medical Technology (02506), under the trend of "equalization" of inference large models, is expected to maintain long-term competitiveness in medical AI due to its years of deep cultivation in China’s Medical Industry and its product synergy advantages across three major terminals. The report indicates that the company is currently trading at a valuation multiple of 26.1 times P/S and 29.8 times PB, which is higher than comparable companies in China and the United States. The report also mentions that the company's financial performance has been relatively stable in recent years, predicting that its revenue for the full year of 2024 will grow year-on-year at a rate higher than that of the previous year. As the company's AI technology continues to iterate, the revenue source is gradually shifting from grassroots hospitals to tiered hospitals.
Sidea Semiconductor Launches Up to 545.4 Million Yuan Shenzhen IPO
Hong Kong stocks movement | China-Affiliated Brokerages collectively rise as Institutions state that mergers and acquisitions in the brokerage industry remain a configuration direction, and the high growth trend in performance for the first half of the ye
China-Affiliated Brokerage stocks collectively rose. As of the time of writing, China International Capital Corporation (03908) increased by 4.2%, reaching HKD 15.86; China Merchants (06099) rose by 4.1%, reaching HKD 15.2; CSC (06066) climbed by 3.8%, reaching HKD 10.38; GTJA (02611) rose by 3.68%, reaching HKD 12.96; China Galaxy (06881) increased by 3.44%, reaching HKD 8.41.
China Merchants: The leading gold and jewelry brands are starting the path of product differentiation upgrades, with a focus on CHOW TAI FOOK and others.
China Merchants released a Research Report stating that after the rapid rise in Gold prices and the differentiation of terminal demand in 2024, the current channel dividends in the Gold and jewelry Industry have peaked, and leaders are embarking on a path of product differentiation upgrades. Considering that the Industry is about to enter the low base phase in Q2, companies that possess strong product power and differentiated competitiveness and show marginal improvement are worth focusing on, such as CHOW TAI FOOK (01929), Lao Pu Gold (06181), and Guangdong CHJ Industry (002345.SZ). The main viewpoints of China Merchants are as follows: The Gold and jewelry Industry is transforming from channel-driven to product power-driven. Since 2020, Gold prices have been fluctuating upward.
GF Securities Issues 3 Billion Yuan Bonds
COWmustMoo OP : wow..
COWmustMoo OP : anyone looking at this?